Public reporting on pharmaceutical industry-led access programs: alignment with the WHO medicine programs evaluation checklist.

ABSTRACT:

Background

There has been increased demand for greater public accountability and transparency of private sector-led global health partnership programs. This study critically reviews and pilot tests the World Health Organization (WHO) medicine program checklist as a framework for public reporting and assessing of programs.

Methods

We reviewed each question on the WHO checklist for clarity and usability. Next, we pilot tested the subset of checklist questions focused on program assessment. We extracted and analyzed publicly available information on one randomly selected program from each of the 20 largest research-based biopharmaceutical companies. For each program, we assessed whether publicly available information allowed for an assessment of each relevant question in the ch

SUBMITTER: Umeh CA 

PROVIDER: S-EPMC7098075 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature